Relates to coverage for treatments to slow the progression of Alzheimer's disease and related dementias
REFERRED TO INSURANCE
Email me when A 10748 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 10748. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill forces all comprehensive medical insurance policies in New York—including individual, group, and corporate plans—to pay for medically necessary diagnostic tests and FDA‑approved drugs that slow Alzheimer’s disease and related dementias, as prescribed by a licensed doctor. It also bans insurers from imposing step‑therapy requirements on those treatments. This expands access for patients and families while obligating insurers to adjust their coverage rules.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 10748
3 free questions a day, no accountHistory
- REFERRED TO INSURANCE
Sponsors
- Angelo Santabarbara (D) · sponsor
- Andrew Hevesi
- Erik Dilan
- Judy Griffin
- Kalman Yeger
- Vivian Cook
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 10748 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 10748 freeOr ask your AI assistant about A 10748 directly:
Add to Claude, ChatGPT or Cursor